
UUBO Pro Bono Team Attends Hospital for Humanity’s 2025 Open Day
Our Pro Bono team, including Deputy Managing Partner and Practice Co-Head Ozofu Ogiemudia, Senior Associate Kelechi Ibe, and Associate Dumebi Anike-Nweze, had the privilege of

Our Pro Bono team, including Deputy Managing Partner and Practice Co-Head Ozofu Ogiemudia, Senior Associate Kelechi Ibe, and Associate Dumebi Anike-Nweze, had the privilege of

Lolale Ososami (Partner), Amina Ibrahim (Partner), and Etido David (Senior Associate) of Udo Udoma & Belo-Osagie’s Mining team have contributed the Nigerian chapter to Panoramic:

Contracts are an important part of both routine transactions and complex commercial relationships, but while focus is often placed on formation and performance, termination is

UUBO – FAQs for Private Capital Players – Nigeria’s Investments and Securities Act 2025-UUBO-ADM-0233 (1)

The new Investments and Securities Act 2025 is here – and it reshapes the game for private capital in Nigeria. For sponsors, managers, investors, and

UPDATED DETAILED ANALYSIS OF ISA 2025 – WHAT IS CHANGING FOR PE AND VC FUNDS (1)The new Investments and Securities Act 2025 is here –

The Nigerian Senate has passed President Tinubu’s 4 (four) Tax Reform Bills (the “Bills”), following the House of Representatives’ earlier passage of the Bills. As

Festus Onyia (Partner), Titilola Olatunde-Fasogbon (Senior Associate), and Michael Ugah (Senior Associate) of Udo Udoma & Belo-Osagie’s Dispute Resolution team have contributed the Nigerian chapter

On 29 March 2025, the President of the Federal Republic of Nigeria, President Bola Ahmed Tinubu, signed the Investment and Securities Act 2025 into law.

Nigeria’s healthcare sector is embracing digital innovation, with services like telemedicine, e-pharmacies and mobile health platforms gaining acceptance. While these tools promise improved access and
Please take a moment to review our Privacy Policy. It explains how we collect, use, and protect your personal data in accordance with the Nigeria Data Protection Act 2023.
By clicking “Continue,” you acknowledge that you have read and understood our Privacy Policy.
If we require your consent for specific data uses (e.g., direct marketing, cross-border data transfer or profiling), we will ask for it separately.